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Bipolar disorder is a common, complex psychiatric disorder characterized by mania and 
depression. The disease aggregates in families, but despite much effort, it has been 
difficult to delineate the basic genetic model or identify specific genetic risk factors.
Not only single gene Mendelian transmission and common variant hypotheses
but also multivariate threshold models and oligogenic quasi-Mendelian modes 
of inheritance have dominated the discussion at times. Almost complete sequence 
information of the human genome and falling sequencing costs now offer the opportunity 
to test these models in families in which the disorder is transmitted over several genera-
tions. Exome-wide sequencing studies have revealed an astonishing number of rare and 
potentially damaging mutations in brain-expressed genes that could have contributed 
to the disease manifestation. However, the statistical analysis of these data has been 
challenging, because genetic risk factors displayed a high degree of dissimilarity across 
families. This scenario is not unique to bipolar disorder, but similar results have also been 
found in schizophrenia, a potentially related psychiatric disorder. Recently, our group 
has published data which supported an oligogenic genetic model of transmission in a 
family with bipolar disorder. In this family, three affected siblings shared rare, damaging 
mutations in multiple genes, which were linked to stress response pathways. These
pathways are also the target for drugs frequently used to treat bipolar disorder. This 
article discusses these findings in the context of previously proclaimed disease models 
and suggests future research directions, including biological confirmation and phenotype 
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introduction
“Manic-depressive illness magnifies common human experiences to larger-than-life proportions” 
(1). This opening sentence to Goodwin and Jamison’s acclaimed and comprehensive book on bipolar 
disorder places the often extreme and strange-appearing symptoms of mania and depression in a 
more comprehensible framework of shared human experiences. Bipolar disorder is a severe, complex 
psychiatric disorder, but still, it is so common that most people likely know a friend, a neighbor, or 
even a family member affected with this disease. After all, with an estimated prevalence rate of 2.4% 
(2) and a world population of 7 billion people, it is expected that several million patients might suffer 
from bipolar disorder worldwide. The core symptoms of bipolar disorder are episodes of abnor-
mally elevated, expansive, and irritable mood accompanied by inflated self-esteem and grandiosity. 
Decreased need for sleep, increased talkativeness, and flight of ideas, could also be present, in addition 
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to excessive goal-directed activity and extreme involvement in 
pleasurable activities, which frequently are associated with a 
high potential for painful consequences (3). To meet diagnostic 
criteria, the symptoms must have caused marked impairment in 
social and occupational functioning or required hospitalization 
to prevent harm to oneself or others. Symptoms of depression can 
precede or follow manic episodes, and sometimes even accom-
pany manic episodes, although they are not required for making 
the diagnosis. Psychotic symptoms, such as hallucinations and/or 
delusions, occur in about 50% of bipolar disorder patients, sug-
gesting some symptomatic and even pathophysiological overlap 
with schizophrenia (4). For many patients, the mood symptoms 
can be so agonizing that suicide seems to be the only escape (2). 
Bipolar disorder appears to have strong genetic risk factors. 
Twin studies have suggested a monozygotic concordance rate of 
0.43, and population-based family risk studies have estimated a 
heritability rate of about 58% (5, 6). Environmental risk factors, 
such as trauma (7, 8), infection, and inflammation (9), have been 
found to contribute to a lesser degree. Despite the widespread 
occurrence, the cause of the disease remains elusive.
early Models of disease Transmission and 
Heritability in Bipolar disorder
In some families, bipolar disorder has been transmitted over 
several generations, closely resembling a Mendelian disorder 
(10, 11). This observation had originally inspired researchers 
to study rare, large multi-generational pedigrees under the 
assumption of a single gene with large effect size and autosomal 
dominant, recessive, or X-linked inheritance (12, 13). After initial 
enthusiasm supported by strong genetic linkage signals, it was 
quickly discovered that these results could not be replicated 
(14). Incomplete penetrance, etiological heterogeneity, and 
recombination events might have contributed to the replication 
failure. However, it was also likely that the underlying disease 
model was not supported by the data. After all, not all segregation 
studies had supported a disease model built on a single major 
disease locus (15–18). The high frequency in the population of 
bipolar disorder also clearly distinguished the disease from rare 
Mendelian disorders. As a consequence, the idea of a single major 
risk locus was quickly rejected (19, 20).
why is Bipolar disorder so  
common in the Population?
The question of why and how severe and debilitating disorders, 
such as bipolar disorder, could have persisted in the population 
at a relatively high rate of about 2–4% is among the leading 
questions of evolutionary epidemiology (21, 22). According to 
Darwinian Theory, common, positively selected traits provided 
an evolutionary advantage, but in the case of some traits, left 
almost all members of a population vulnerable to the disease 
(Figure 1) (23). Supporting evidence has come from comparisons 
of the human genome to the genome of the chimpanzee, which 
revealed evidence for positive selection in the opioid receptor 
genes (24) and immune response genes (25, 26). These studies 
provided support for a link between entire genes or even gene 
families and common human traits, such as creativity and novelty 
seeking, which might have not only provided an evolutionary 
advantage but also made all humankind susceptible to addiction 
and other psychiatric disorders (27).
On the other hand, diseases are thought to be subject to negative 
selection. Only in rare cases has evolutionary selection seemed to 
have led to the accumulation of Mendelian disorders. An often 
cited text-book example for a disease with evolutionary advantage 
is sickle cell anemia, a Mendelian disorder with a population 
frequency of up to 0.16% in African Americans. Heterozygous 
mutations in a single disease-causing gene have provided a pro-
tective effect against malaria, a common environmental threat in 
Africa, leading to higher allele frequencies for the protective allele 
than expected based on mutation rates alone (28–30). However, 
examples of other disorders have not supported the theory of 
evolutionary advantages of common variants. The Mendelian 
disorder cystic fibrosis has reached relatively high prevalence in 
FiGuRe 1 | evolution-based hypothesis about traits and diseases.
KeY coNcePT 4 | Genetic risk factors
The genetic code contains information about the structure, function, and 
timely expression of proteins, which are the basic building blocks of the 
cell machinery. Changes in the base-pair sequence of this code (mutations) 
could lead to disease-causing changes in the structure and/or function of the 
encoded proteins. The protein expression level or timing might also be altered.
KeY coNcePT 1 | single gene Mendelian transmission
Many rare, Mendelian disorders, such as cystic fibrosis, are caused by muta-
tions in one or a few genes. The disease manifests if one allele (dominant 
inheritance) or both alleles (recessive inheritance) of a gene carry the mutation 
and environmental influences are of minor importance.
KeY coNcePT 3 | oligogenic quasi-Mendelian mode of inheritance
This genetic model conceptualizes disorders as being influenced by a 
small number of genetic mutations in genes that are potentially related to a 
specific biological function. A disorder occurs if the interacting mutations are 
present and environmental factors are considered of minor importance. The 
inheritance pattern of the disease follows Mendelian rules if all mutations are 
inherited jointly.
KeY coNcePT 2 | Multivariate threshold model
This genetic model is concerned with quantitative traits that are conceptuali-
zed as being normally distributed in the population. A change in the phenotype 
occurs if a threshold of genetic or environmental influences has been reached. 
The relationship between traits and disease is often unclear.
FiGuRe 2 | Genetic models of disease transmission in bipolar disorder.
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the population, but increased vulnerability to mutation at a spe-
cific location in the disease-causing gene, and not evolutionary 
advantage, likely contributed to the increased allele frequency of 
the disease-causing CFTRΔF508 mutation (31). Since more than 
1,000 rare mutations in other parts of the gene have been identified 
as disease-causing alleles, an evolutionary advantage of a single 
mutation appears to be less likely. Last, but not least, population 
bottleneck could have resulted in disease aggregation in certain 
populations. For example, Tay–Sachs disease is a genetically 
heterogeneous Mendelian disorder with an increased prevalence 
of 0.04% in the Jewish population (32). The disease is caused by 
more than 30 different mutated alleles, but because of population 
isolation and selective mating, the disease could increase in preva-
lence. These examples demonstrate that disease-causing alleles 
are relatively rare, even in relatively common diseases and that, 
with  a few exceptions, evolutionary advantages do not explain the 
increased population prevalence of severe disorders.
The “common disease–common variant” 
Hypothesis
Even though the rare nature of disease-causing mutations had 
been well accepted by Mendelian geneticists, genetic epidemiolo-
gists had been puzzled by the frequent occurrence of common 
disorders in the population, and also by the discovery of millions 
of common genetic polymorphisms across the genome that 
were not well explained by Darwinian Theory. It was tempt-
ing to claim that common genetic polymorphisms could be 
linked to common complex disorders (33). In addition, it had 
been noticed that association analyses in population samples 
provided increased statistical power over family based linkage 
analysis (34). Technical advantages in array-based approaches 
finally paved the way for genome-wide genotyping of common 
single-nucleotide polymorphisms (SNPs) and association testing 
with disease. Genome-wide association studies were widely dis-
seminated across clinical and statistical fields, and thousands of 
publications followed without further questioning the biological 
foundation of the common disease-common variant hypothesis. 
Overall, these studies have revealed a complex genetic structure 
influencing almost all examined traits and disorders, including 
bipolar disorder (35–38), but the functional consequences of the 
common variants remained mostly elusive (39, 40). Overall, the 
results of these studies have not supported the assumption of a 
common genetic disease-causing risk factor in bipolar disorder 
or a link to positive adaptation. Instead, evidence is accumulating 
that founder effects and drift, but not Darwinian selection, might 
have caused common allele frequency variability, and a causal 
link between common variants and common disorders has not 
been substantiated for most disorders (21, 41, 42).
Alternatives to the common disease–
common variant Hypothesis
While a model of non-random, natural selection had dominated 
the search for genetic risk factors in traits that might have been 
related to psychiatric disorders, alternative explanations had also 
been considered (Figure 2). One hypothesis that had gained atten-
tion proposed a more complex polygenic, or even multifactorial, 
model of transmission (43). An example of polygenic transmission 
is eye color, which seems to be a purely genetic trait. According 
to this model, random mutations in many genes, some of which 
with a dominant effect, influence the expression of the trait in the 
population (44, 45). On the other hand, height is a trait that is 
influenced by a complex interplay of genetic and environmental 
factors (46). An adaptation of this model to psychiatric disorders 
was the liability threshold model (47). According to this theory, 
liability to psychiatric disorders or “traits” related to susceptibility 
follows a continuous distribution in the population. However, 
this model was contradicted by the finding that family risk did not 
follow this pattern (48–50). Furthermore, in many families, the 
disease was transmitted through the paternal and the maternal 
lineage. This pattern of transmission, also known as assortative 
mating, contributed to the aggregation of risk factors in a few 
families with multiple affected family members, whereas in most 
families the risk was low (51). In general, family studies have not 
supported a multifactorial threshold model of disease for bipolar 
disorder (52, 53). Instead, mathematical model fitting in families 
with bipolar disorder suggested an oligogenic, quasi-Mendelian 
mode of inheritance with significant locus heterogeneity (54).
closing the circle or is it a spiral?
In 1990s, when large, multi-generational families were first 
studied, neither the analytical tools nor the biological knowledge 
were available to solve the problem of a complex, oligogenic 
inheritance. However, with almost complete information on the 
human genome available and rapidly falling sequencing costs, the 
time seemed to be right to revisit disease models proposed more 
than 20 years ago. Since bipolar disorder is inherited in families, 
pedigrees seemed to be a natural choice to test the hypothesis 
of a quasi-Mendelian, oligogenic model of disease transmis-
sion (Figure  3). According to this model, it was expected that 
KeY coNcePT 5 | common complex disorders
Some common medical conditions, such as diabetes or high-blood pressure, 
are believed to be caused by genetic and environmental factors. Therefore, 
the transmission in families might not follow a simple Mendelian mode of 
transmission. According to this model, an individual might not manifest the 
disease, even though he or she carries a risk mutation, if the environmental 
exposure has not occurred.
FiGuRe 3 | identification and confirmation of genetic risk variants in 
bipolar disorder.
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a few rare and likely functional variants were shared among the 
affected family members with both parents contributing to the 
disease risk. Likewise, unaffected family members would not 
carry the damaging variants. Not only to avoid biases that could 
be introduced by selection of candidate genes but also to keep the 
focus on gene-coding regions for which functional information 
was available, we favored an exome-wide sequencing approach 
(55). The results of our study suggested that multiple, very rare, 
and likely protein-damaging mutations in highly conserved gene 
regions had affected genes that were linked in a single pathophysi-
ological pathway regulated by MAP kinases. All mutations in this 
family had likely affected a specific signaling pathway known to 
be involved in the response to mood stabilizing medications. This 
finding supported the oligogenic hypothesis of genetic risk in 
bipolar disorder. While a statistical proof of disease association will 
require larger data sets, these results, nevertheless, point to genes 
and signaling pathways in which the functional consequences of 
the mutations could be tested in cell culture and animal models 
(Figure 3). Since the data have been published, several groups 
have completed candidate gene sequencing in population and 
family samples, and exome-wide sequencing in Old Order Amish 
families (40, 56–58). These studies have found significant haplo-
type and locus heterogeneity, and further rejected the hypothesis 
of a single major risk gene for bipolar disorder.
While exome-wide and genome-wide sequencing studies 
in bipolar disorder are still rare, we have tried to find further 
support for our hypothesis in studies on a potentially related 
psychiatric disorder, schizophrenia. These studies have revealed 
a high degree of de novo mutations and rare protein-damaging 
genomic variants in patients with schizophrenia (59–69). The 
largest exome-wide study available to date is a population-based 
Swedish study of 5,079 cases and controls (70, 71). The results 
of this study supported the hypothesis of significant locus 
heterogeneity in schizophrenia. Despite an increased burden of 
potentially damaging rare mutations in cases, no locus-specific 
associations reached genome-wide statistical significance. The 
apparent controversy that bipolar disorder appears to be quasi-
Mendelian in families, but still very common in the population, 
could be due to rare mutations in hundreds or thousands of 
contributing genes, a disease model that has become apparent 
in intellectual disability and autism (72). Therefore, it will be 
essential to collect and annotate all identified genetic variants 
in psychiatric patients and to create a comprehensive searchable 
database to facilitate genetic testing and personalized genomic 
medicine (73).
where to go from Here?
In bipolar disorder and schizophrenia, increasing evidence 
supports the role of rare, disease-causing mutations in brain-
expressed genes. As a single major risk gene has become highly 
unlikely, the need for new analytical and statistical approaches 
has grown. Locus heterogeneity and private mutations challenge 
hypothesis testing with established statistical methods. However, 
even for statistically significant associations, the translation into 
clinical applications will ultimately require the demonstration 
of biological significance. So far, genome-wide approaches have 
only scratched the surface of genomic variability. Rare muta-
tions in gene-coding regions certainly constitute only the tip 
of the iceberg and do not capture the full spectrum of potential 
disease-causing genomic changes. For example, researchers have 
only begun to explore the vast functional diversity of non-coding 
DNA. Functional exploration of micro RNAs (miRNAs), small 
nuclear RNAs (snoRNAs), and long non-coding RNAs (lncRNAs) 
could reveal their role in pathway regulation and other cellular 
processes (74). Furthermore, a growing number of investigators 
have requested a balanced approach to DNA-based and protein-
based studies (75). The field of proteomics has already uncovered 
the complexities of context-specific and cell-type-specific 
protein function in a complex network of potential interactions. 
Posttranslational modifications and their consequences on the 
structure, function, and intracellular location of the modified 
proteins provide ever increasing possibilities of variability and 
interaction. Disease mechanisms might also involve cell-derived 
membrane vesicles (CVM), which play a role in cell–cell com-
munication. Interdisciplinary approaches will be necessary to 
clearly elucidate the functional consequences of mutations and 
protein modifications in the context of intracellular events and 
pathways, as well as cell networks and developmental processes.
summary and Recommendations
To tackle the complexity of psychiatric disorders, we will need a 
balanced and broad approach to biological and social risk factors 
in which competing and complementary ideas could receive equal 
financial support. In a scientific culture that is reflected in phrases, 
such as “Go big or go home,” the focus is on large heterogeneous 
population-based samples. While this approach might be useful 
for studying common traits that are shared by most members 
of a population, it is less suitable for diseases that are transmit-
ted in families and in which each family may carry a unique 
combination of susceptibility genes. Rare genomic risk factors 
with moderately strong effect could be best approached through 
exome-wide or genome-wide sequencing of multi-generational 
families in which the disease is transmitted in a Mendelian or 
“quasi-Mendelian” mode. Based on recent results, it should be 
recognized that these approaches are at least complementary in 
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studies of schizophrenia and other neuropsychiatric disorders. 
Rigorous hypothesis testing and rejection of unsupported ideas, 
as well as transparency and replication of results, will ultimately 
lead to progress in our understanding of disease processes and 
risk factors. Reporting of positive, as well as negative, results will 
increase transparency and reduce redundancy of efforts.
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